Clinical trial
Costs and Effects of Early Switch of Intravenous to Oral Antibiotics in Severe Community-Acquired Pneumonia: a Multicenter Randomized Trial
NCT00273676 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Costs and Effects of Early Switch of Intravenous to Oral Antibiotics in Severe Community-Acquired Pneumonia: a Multicenter Randomized Trial
- Lead sponsor
- UMC Utrecht
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2000
- Completion date
- March 31, 2004
- Enrollment
- 500
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
severe communtity-acquired pneumonia